Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 21
2008 41
2009 60
2010 66
2011 71
2012 90
2013 71
2014 68
2015 71
2016 62
2017 53
2018 85
2019 93
2020 109
2021 31
Text availability
Article attribute
Article type
Publication date

Search Results

855 results
Results by year
Filters applied: . Clear all
Page 1
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum.
Barnes GD, Burnett A, Allen A, Blumenstein M, Clark NP, Cuker A, Dager WE, Deitelzweig SB, Ellsworth S, Garcia D, Kaatz S, Minichiello T. Barnes GD, et al. J Thromb Thrombolysis. 2020 Jul;50(1):72-81. doi: 10.1007/s11239-020-02138-z. J Thromb Thrombolysis. 2020. PMID: 32440883 Free PMC article.
The goal of this document is to provide guidance from the Anticoagulation Forum, a North American organization of anticoagulation providers, regarding use of anticoagulant therapies in patients with COVID-19. We discuss in-hospital and post-discharge venous thromboembolism …
The goal of this document is to provide guidance from the Anticoagulation Forum, a North American organization of anticoagulation providers, …
Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.
Aryal MR, Gosain R, Donato A, Pathak R, Bhatt VR, Katel A, Kouides P. Aryal MR, et al. Curr Cardiol Rep. 2020 Jun 11;22(7):52. doi: 10.1007/s11886-020-01327-9. Curr Cardiol Rep. 2020. PMID: 32529517 Free PMC article. Review.
However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients. RECENT FINDINGS: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose …
However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients. R …
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.
Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, Levi M, Samama CM, Thachil J, Giannis D, Douketis JD; Subcommittee on Perioperative, Critical Care Thrombosis, Haemostasis of the Scientific, Standardization Committee of the International Society on Thrombosis and Haemostasis. Spyropoulos AC, et al. J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929. J Thromb Haemost. 2020. PMID: 32459046 Free PMC article.
Cardiovascular disease and, in particular, venous thromboembolism (VTE) has emerged as an important consideration in the management of hospitalized patients with COVID-19. The diagnosis of VTE using standardized objective testing is problematic in these patients, given the …
Cardiovascular disease and, in particular, venous thromboembolism (VTE) has emerged as an important consideration in the management of ho
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH. Kahn SR, et al. Chest. 2012 Feb;141(2 Suppl):e195S-e226S. doi: 10.1378/chest.11-2296. Chest. 2012. PMID: 22315261 Free PMC article.
BACKGROUND: This guideline addressed VTE prevention in hospitalized medical patients, outpatients with cancer, the chronically immobilized, long-distance travelers, and those with asymptomatic thrombophilia. ...For acutely ill hospitalized medical patients at low ri …
BACKGROUND: This guideline addressed VTE prevention in hospitalized medical patients, outpatients with cancer, the chronically immobi …
Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness.
Goldenberg NA, Sochet A, Albisetti M, Biss T, Bonduel M, Jaffray J, MacLaren G, Monagle P, O'Brien S, Raffini L, Revel-Vilk S, Sirachainan N, Williams S, Zia A, Male C; Pediatric/Neonatal Hemostasis and Thrombosis Subcommittee of the ISTH SSC. Goldenberg NA, et al. J Thromb Haemost. 2020 Nov;18(11):3099-3105. doi: 10.1111/jth.15073. J Thromb Haemost. 2020. PMID: 33174388 Review.
BACKGROUND: Observational studies indicate that children hospitalized with COVID-19-related illness, like adults, are at increased risk for venous thromboembolism (VTE). A multicenter phase 2 clinical trial of anticoagulant thromboprophylaxis in children hospitalized
BACKGROUND: Observational studies indicate that children hospitalized with COVID-19-related illness, like adults, are at increased ri …
Deep venous thrombosis and venous thromboembolism prophylaxis.
Buesing KL, Mullapudi B, Flowers KA. Buesing KL, et al. Surg Clin North Am. 2015 Apr;95(2):285-300. doi: 10.1016/j.suc.2014.11.005. Surg Clin North Am. 2015. PMID: 25814107 Review.
"Venous thromboembolism (VTE) remains a significant risk for all surgical patients, despite validated guidelines. Development of VTE remains a high risk in hospitalized surgical patients, leading to complications in up to 30%. ...
"Venous thromboembolism (VTE) remains a significant risk for all surgical patients, despite validated guidelines. Development of VTE remains …
Venous thromboembolism in inflammatory bowel disease.
Cheng K, Faye AS. Cheng K, et al. World J Gastroenterol. 2020 Mar 28;26(12):1231-1241. doi: 10.3748/wjg.v26.i12.1231. World J Gastroenterol. 2020. PMID: 32256013 Free PMC article. Review.
Despite the increased risk of VTE among IBD patients and the safety of pharmacologic prophylaxis, adherence rates among hospitalized IBD patients appear to be low. Furthermore, recent data suggests that there is a population of high risk IBD patients who may benefit from p …
Despite the increased risk of VTE among IBD patients and the safety of pharmacologic prophylaxis, adherence rates among hospitalized
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.
Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, Kahn SR, Rahman M, Rajasekhar A, Rogers FB, Smythe MA, Tikkinen KAO, Yates AJ, Baldeh T, Balduzzi S, Brożek JL, Ikobaltzeta IE, Johal H, Neumann I, Wiercioch W, Yepes-Nuñez JJ, Schünemann HJ, Dahm P. Anderson DR, et al. Blood Adv. 2019 Dec 10;3(23):3898-3944. doi: 10.1182/bloodadvances.2019000975. Blood Adv. 2019. PMID: 31794602 Free PMC article.
Cancer and Venous Thromboembolic Disease: A Review.
Donnellan E, Khorana AA. Donnellan E, et al. Oncologist. 2017 Feb;22(2):199-207. doi: 10.1634/theoncologist.2016-0214. Epub 2017 Feb 7. Oncologist. 2017. PMID: 28174293 Free PMC article. Review.
In general, thromboprophylaxis is recommended for most patients hospitalized with active cancer. Furthermore, outpatient thromboprophylaxis may be used in carefully selected high-risk ambulatory patients. ...
In general, thromboprophylaxis is recommended for most patients hospitalized with active cancer. Furthermore, outpatient thromboproph …
Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States.
Abe K, Kuklina EV, Hooper WC, Callaghan WM. Abe K, et al. Semin Perinatol. 2019 Jun;43(4):200-204. doi: 10.1053/j.semperi.2019.03.004. Epub 2019 Mar 9. Semin Perinatol. 2019. PMID: 30935751 Free PMC article. Review.
In the U.S., deaths due to pulmonary embolism (PE) account for 9.2% of all pregnancy-related deaths or approximately 1.5 deaths per 100,000 live births. ...Although deep vein thrombosis rates have decreased during this time-period, PE rates have remained relatively unchang …
In the U.S., deaths due to pulmonary embolism (PE) account for 9.2% of all pregnancy-related deaths or approximately 1.5 deaths per 1 …
855 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page